Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.

Knip M, Åkerblom HK, Becker D, Dosch HM, Dupre J, Fraser W, Howard N, Ilonen J, Krischer JP, Kordonouri O, Lawson ML, Palmer JP, Savilahti E, Vaarala O, Virtanen SM; TRIGR Study Group.

JAMA. 2014 Jun 11;311(22):2279-87. doi: 10.1001/jama.2014.5610.

2.

Growth differences between North American and European children at risk for type 1 diabetes.

Nucci AM, Becker DJ, Virtanen SM, Cuthbertson D, Softness B, Huot C, Wasikowa R, Dosch HM, Akerblom HK, Knip M; TRIGR Study Group.

Pediatr Diabetes. 2012 Aug;13(5):425-31. doi: 10.1111/j.1399-5448.2011.00840.x. Epub 2012 Jan 17.

3.

Effect of weight loss on inflammation in patients with mild obstructive sleep apnea.

Sahlman J, Seppä J, Herder C, Peltonen M, Peuhkurinen K, Gylling H, Vanninen E, Tukiainen H, Punnonen K, Partinen M, Uusitupa M, Tuomilehto H.

Nutr Metab Cardiovasc Dis. 2012 Jul;22(7):583-90. doi: 10.1016/j.numecd.2010.10.007. Epub 2010 Dec 28.

PMID:
21193295
4.

Sustained improvement in mild obstructive sleep apnea after a diet- and physical activity-based lifestyle intervention: postinterventional follow-up.

Tuomilehto H, Gylling H, Peltonen M, Martikainen T, Sahlman J, Kokkarinen J, Randell J, Tukiainen H, Vanninen E, Partinen M, Tuomilehto J, Uusitupa M, Seppä J; Kuopio Sleep Apnea Group.

Am J Clin Nutr. 2010 Oct;92(4):688-96. doi: 10.3945/ajcn.2010.29485. Epub 2010 Aug 11.

5.

Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea.

Tuomilehto HP, Seppä JM, Partinen MM, Peltonen M, Gylling H, Tuomilehto JO, Vanninen EJ, Kokkarinen J, Sahlman JK, Martikainen T, Soini EJ, Randell J, Tukiainen H, Uusitupa M; Kuopio Sleep Apnea Group.

Am J Respir Crit Care Med. 2009 Feb 15;179(4):320-7. doi: 10.1164/rccm.200805-669OC. Epub 2008 Nov 14.

PMID:
19011153
6.

Effect of weight reduction on rhinometric measurements in overweight patients with obstructive sleep apnea.

Kemppainen T, Ruoppi P, Seppä J, Sahlman J, Peltonen M, Tukiainen H, Gylling H, Vanninen E, Tuomilehto H.

Am J Rhinol. 2008 Jul-Aug;22(4):410-5. doi: 10.2500/ajr.2008.22.3203.

PMID:
18702908
7.

Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function.

Rytilä P, Ghaly L, Varghese S, Chung W, Selroos O, Haahtela T; Airway Inflammation Study Group.

Eur Respir J. 2008 Oct;32(4):989-96. doi: 10.1183/09031936.00062307. Epub 2008 May 28.

8.

Hypertonic saline cough provocation test with salbutamol pre-treatment: evidence for sensorineural dysfunction in asthma.

Koskela HO, Purokivi MK, Kontra KM, Taivainen AH, Tukiainen HO.

Clin Exp Allergy. 2008 Jul;38(7):1100-7. doi: 10.1111/j.1365-2222.2008.02996.x. Epub 2008 May 6.

PMID:
18462452
9.
10.

Aspergillus fumigatus challenge increases cytokine levels in nasal lavage fluid.

Stark H, Roponen M, Purokivi M, Randell J, Tukiainen H, Hirvonen MR.

Inhal Toxicol. 2006 Dec;18(13):1033-9.

PMID:
16966303
11.

Experimental PVC material challenge in subjects with occupational PVC exposure.

Tuomainen A, Stark H, Seuri M, Hirvonen MR, Linnainmaa M, Sieppi A, Tukiainen H.

Environ Health Perspect. 2006 Sep;114(9):1409-13.

12.

Short-term and seasonal variations of exhaled and nasal NO in healthy subjects.

Stark H, Purokivi M, Kiviranta J, Randell J, Tukiainen H.

Respir Med. 2007 Feb;101(2):265-71. Epub 2006 Jun 22.

13.

Determinants of the bronchodilation response to salbutamol on histamine-induced bronchoconstriction.

Koskela HO, Kiviniemi V, Purokivi MK, Taivainen AH, Tukiainen HO.

Respir Med. 2006 Oct;100(10):1760-6. Epub 2006 Mar 24.

14.

The effects of Aspergillus fumigatus challenge on exhaled and nasal NO levels.

Stark HJ, Randell JT, Hirvonen MR, Purokivi MK, Roponen MH, Tukiainen HO.

Eur Respir J. 2005 Nov;26(5):887-93.

15.

Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients.

Kannisto S, Laatikainen A, Taivainen A, Savolainen K, Tukiainen H, Voutilainen R.

Eur J Endocrinol. 2004 May;150(5):687-90.

16.

The remediation of mold damaged school--a three-year follow-up study on teachers' health.

Patovirta RL, Husman T, Haverinen U, Vahteristo M, Uitti JA, Tukiainen H, Nevalainen A.

Cent Eur J Public Health. 2004 Mar;12(1):36-42.

PMID:
15068207
17.

Inhalation challenge with bovine dander allergens: who needs it?

Koskela H, Taivainen A, Tukiainen H, Chan HK.

Chest. 2003 Jul;124(1):383-91.

PMID:
12853550
18.

Delaying decline in pulmonary function with physical activity: a 25-year follow-up.

Pelkonen M, Notkola IL, Lakka T, Tukiainen HO, Kivinen P, Nissinen A.

Am J Respir Crit Care Med. 2003 Aug 15;168(4):494-9. Epub 2003 Jun 5.

PMID:
12791579
19.

Nitric oxide alone is an insufficient biomarker of exposure to microbes in a moisture-damaged building.

Purokivi M, Hirvonen MR, Randell J, Roponen M, Tukiainen H.

Inhal Toxicol. 2002 Dec;14(12):1279-90.

PMID:
12454791
20.

Threshold levels of purified natural Bos d 2 for inducing bronchial airway response in asthmatic patients.

Zeiler T, Taivainen A, Mäntyjärvi R, Tukiainen H, Rautiainen J, Rytkönen-Nissinen M, Virtanen T.

Clin Exp Allergy. 2002 Oct;32(10):1454-60.

PMID:
12372125
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk